Search

You searched for "AMM"

1865 results found

RaScaL Study

1 June 2015 | | EYE - Vitreo-Retinal
The RaScaL study was a six month, single-centre, controlled, prospective phase I/II study in which subjects with diabetic macular oedema (DME) and associated peripheral nonperfusion on ultrawide-field fluorescein angiography (UWFA) were randomised to: (1) study arm: ranibizumab (0.5 mg) injection...

Leadership skills training through the COECSA-RCOphth LINK

1 June 2017 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The Lead Forward project was an initiative of the VISION 2020 LINKS Programme, funded by the Department for International Development (DFID) via the Tropical Health Education Trust (THET). It aimed to improve the quality of medical leadership within VISION 2020...

A randomised, controlled trial of oral propranolol in infantile haemangioma

1 April 2015 | | EYE - Oculoplastic, EYE - Orbit
Since its use was first reported in the New England Journal in 2008, propranolol has become the preferred treatment for infantile haemangiomas. However, there is no consensus as to the optimum dose or duration of treatment and there is a...

Inhibiting high-risk corneal allografts

1 October 2014 | | EYE - Cornea, EYE - General | T regulatory cells, Tim-1, high-risk corneal allograft rejection, mice
The cornea is an immune privileged site and as such corneal transplants are very successful. However, in situations where this privilege is lost the failure rises substantially. To combat rejection inhibition of the immune responses depends on steroids and other...
British Journal of Ophthalmology Apr 2020 cover image

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in NARMD

5 June 2020 | | EYE - Vitreo-Retinal
This is a six-month, prospective, single-arm study in the UK and Germany. A total of 100 patients were enrolled (one in the primary failure group, 99 in the suboptimal treatment response group), treated three-monthly intravitreal ranibizumab injections (0.5mg), and then...

New team member for Topcon Surgical

27 June 2023 | Recruitment & Personnel
Topcon Great Britain Medical has announced a new addition to the Topcon Surgical team.

Lost in translation

1 June 2022 | | EYE - General
The article that follows is a collection of reflections and observations by Peter (British) and Nathan (Singaporean) living and working in each other’s countries. Peter Cackett “Best thing about this place is it’s not still full of pompous ex-colonials who...

Refractionist’s shoulder?

1 June 2015 | | EYE - General
After hearing the letter-box, I walked to the front door and stooped down to collect my latest edition of Eye News. I winced. Still, at least it would give me something to pass the time on this, my first day...

Booster accelerates EU-funded projects results to create tangible impact

2 December 2024 | EU-funded research, Dissemination, Exploitation, Commercialisation, Research exploitation, Horizon Europe programme, Impact, Research & Innovation, DG RTD
META Group is proud to announce that Booster has been renewed for another four years, with additional and customised services. Funded by the European Commission’s Directorate-General for Research and Innovation (DG RTD) and led by META Group, Booster offers a...

Glaucoma UK’s campaign raises awareness of glaucoma through people’s unique glaucoma stories

26 June 2023 | GLAUCOMA, GAW2023, AWARENESS, GLAUCOMA UK
Glaucoma UK is marking Glaucoma Awareness Week 2023, which will run from 26 June to 2 July 2023.

Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics

9 May 2025 | AI, Artificial intelligence, oculomics, news, Moorfields, Cascader, imaging, industry news
Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...

RNIB introduces ground-breaking framework for Low Vision care

1 March 2024 | optometry, low vision, patient care, practice, guidelines
The Royal National Institute of Blind People (RNIB) is launching the development of a landmark set of guidelines and framework to help low vision clinics provide best practice care, which it will unveil today at a launch event at its state-of-the-art Low Vision Centre in the charity’s headquarters in London.